Skip to content
10-K

Annual Report

RENNOVA HEALTH, INC.

0001493152-23-012549

← back to feed
Filed
Apr 17, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Mar 30, 2023 29.93B sh
Capex FY 2022 · Dec 31, 2022 $35.23K
Operating Cash Flow FY 2022 · Dec 31, 2021 −$8.91M
Short Term Debt FY 2022 · Dec 31, 2021 $8.22M
Cash And Equivalents FY 2022 · Dec 31, 2021 $724.52K
Stockholders Equity FY 2022 · Dec 31, 2021 −$27.3M
Stockholders Equity FY 2022 · Dec 31, 2020 −$49.02M
Current Liabilities FY 2022 · Dec 31, 2021 $46.36M
Total Liabilities FY 2022 · Dec 31, 2021 $46.94M
Current Assets FY 2022 · Dec 31, 2021 $4.72M
Total Assets FY 2022 · Dec 31, 2021 $19.63M
Eps Basic FY 2022 · Dec 31, 2021 −$913.37
Sga Expense FY 2022 · Dec 31, 2021 $7.51M
Net Income FY 2022 · Dec 31, 2021 $5.61M
Operating Income FY 2022 · Dec 31, 2021 −$12.52M
Gross Profit FY 2022 · Dec 31, 2021 $214.56K
Revenue FY 2022 · Dec 31, 2021 $3.22M